In addition to suppressing metastasis by inhibiting tumor-specific expression of vascular endothelial growth factor (VEGF)[25], SSeCKS inhibits parameters of oncogenic motility, such as invasiveness and chemotaxis [26], by re-establishing normalized cytoskeletal architecture including stress fiber and focal adhesion plaque formation. This evidence concerns the gene VEGFA and neoplasm.